Insulin resistance due to statin therapy: A potential contributor to the negation of statin-induced beneficial effects on cardiac remodelling in heart failure?

dc.contributor.authorYalta, Kenan
dc.date.accessioned2024-06-12T11:15:38Z
dc.date.available2024-06-12T11:15:38Z
dc.date.issued2011
dc.departmentTrakya Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.doi10.1016/j.ijcard.2010.04.078
dc.identifier.endpage417en_US
dc.identifier.issn0167-5273
dc.identifier.issue3en_US
dc.identifier.pmid20483495en_US
dc.identifier.scopus2-s2.0-78951472618en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage417en_US
dc.identifier.urihttps://doi.org/10.1016/j.ijcard.2010.04.078
dc.identifier.urihttps://hdl.handle.net/20.500.14551/24001
dc.identifier.volume146en_US
dc.identifier.wosWOS:000286460500029en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Ireland Ltden_US
dc.relation.ispartofInternational Journal Of Cardiologyen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectStatin Theraphyen_US
dc.subjectInsulin Resistanceen_US
dc.subjectCardiac Remodellingen_US
dc.titleInsulin resistance due to statin therapy: A potential contributor to the negation of statin-induced beneficial effects on cardiac remodelling in heart failure?en_US
dc.typeLetteren_US

Dosyalar